Bimiralisib (PQR309)

Bimiralisib (PQR309) is a novel brain-penetrant dual PI3K/mTOR inhibitor with in vitro and in vivo antilymphoma activity. It displays excellent selectivity versus PI3K-related lipid kinases, protein kinases and unrelated targets.

Price Not Available 25mg Bimiralisib (PQR309) Supplier Page

Trivial name	N/A
Catalog Number	S8738
Molecular Formula	C17H20F3N7O2
CAS#	1225037-39-7
Inchi	InChI=1S/C17H20F3N7O2/c18-17(19,20)12-9-13(21)22-10-11(12)14-23-15(26-1-5-28-6-2-26)25-16(24-14)27-3-7-29-8-4-27/h9-10H,1-8H2,(H2,21,22)
Inchi Key	ADGGYDAFIHSYFI-UHFFFAOYSA-N
SMILES	C1COCCN1C2=NC(=NC(=N2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4
Size	25mg
Supplier Page	http://www.selleckchem.com/products/pqr309-bimiralisib.html
Additional Information	https://file.selleck.cn/downloads/struct/pqr309-bimiralisib-chemical-structure-s8738.gif